Stem Cell
Therapy for
Cerebral Palsy
What is Cerebral Palsy?
Cerebral Palsy (CP), is any disorder of movement, learning, hearing, seeing and thinking. Most of these problems occur due to infections or injuries caused to the brain, generally at the time of delivery.
Symptoms:
Symptoms include abnormal movements, abnormal sensations, abnormal muscle tone, decreased intelligence, difficulty sucking or feeding in infants, hearing problems, drooling, irregular breathing, learning disabilities, speech and vision problems, etc.
In conventional therapy, doctors’ tests aim at confirming all the above symptoms. Unfortunately, there is no cure even after the confirmation. The goal of treatment is to help the person be as independent as possible.
Stem Cell Therapy for Cerebral Palsy
Stem cell therapy for Cerebral Palsy aims to induce neurogenesis (regeneration of the affected portion of the brain matrix), improve blood and oxygen flow to the brain and replace damaged neurons. The end goal is to improve the quality of life of the patient. Stem cell therapy may be used in conjunction with, or as an alternative to other conventional treatments.
Mesenchymal stem cells (MSCs) generally derived from patient’s own bone marrow, and are thus considered to be safe, since these cells are from patient’s own body. These cells have ability to home to damaged tissue and are known to secrete several trophic factors to stimulate repair of damaged nervous tissue in both the brain and the spinal cord.
The beneficial effects of these cells after transplantation are thought to result from multiple mechanisms that include neuroprotective, anti-inflammatory, anti-apoptotic, and angiogenic effects. MSCs can rescue neurons and oligodendrocytes from apoptosis through the release of trophic and anti-apoptotic molecules, and they can have anti-inflammatory and anti-proliferative effects on microglial cells and astrocytes, resulting in the induction of a neuroprotective microenvironment. In addition, MSCs can promote the proliferation and maturation of local neural precursor cells, leading to their differentiation into mature neurons and oligodendrocytes.
Because we utilize autologous bone marrow derived mesenchymal stem cells, we are able to offer a safe treatment to any qualified patient. The end goal is to improve the quality of life of the patient. Stem cell therapy may be used in conjunction with, or as an alternative to other conventional treatments.
Please refer to the articles published in renowned medical journals listed below.